Unfortunately, conventional serological tests do not readily differentiate between past and persistent infection, but we have found that the amount of virus-specific IgM in a patient's serum, which characteristically increases in the first few days then disappears six to eight weeks after uncomplicated infection (Brown et al., 1970) , remains raised during the course of certain complications of rubella (Haire and Hadden, 1970) . We believe, by analogy with the congenital rubella syndrome in which rubella virus and rubella IgM coexist for long periods (Baublis and Brown, 1968; Vesikari et al., 1969) and also by analogy with subacute sclerosing panencephalitis, where measles antigen was shown to be present in the brain (Connolly et al., 1967) and was associated with persistent measles IgM , that persistent virus-specific IgM is presumptive evidence of the presence of virus antigen.
For these reasons we decided to look for virus-specific IgM in sera from multiple sclerosis.
Patients, Materials, and Methods Sera were collected from three groups each of 43 patients, matched for sex and consisting of 20 males and 23 females. One group of patients had multiple sclerosis, another had various neurological disorders, and the third "control" group was composed of healthy individuals. The multiple sclerosis patients and the normal controls were also matched for age, to the nearest two years.
Four categories of multiple sclerosis were defined: category 1, probable multiple sclerosis, active, 27 patients; category 2, probable multiple sclerosis, chronic, six patients; category 3, possible multiple sclerosis, active, four patients; and category 4, possible multiple sclerosis, chronic, six patients. "Probable" refers to a typical history of relapses and remissions and/or evidence of more than one lesion in the central nervous system. "Possible" refers to the early stage of the disease or spastic paraparesis without other ascertainable cause. "Active" means that the disease is in relapse or in an active progressive phase. "Chronic" means that the condition remains unchanged.
The 43 patients suffering from other neurological diseases consisted of 16 patients who had Parkinsonism, 7 who had cerebrovascular disease, 7 who had motor neurone disease, 8 who had epilepsy, and the remaining 5 each had a different disease.
The normal control sera were taken from healthy individuals, including patients reporting with injuries at a casualty department.
The sera were coded so that the persons doing the tests did not know the origin of any serum. The multiple sclerosis sera were stored at minus 200C for periods of up to three years. All other sera were stored for two months before testing. Following the preliminary survey four selected patients from the multiple sclerosis group were bled again for confirmatory tests.
A 1 in 5 dilution of patient's serum, heated at 60°C for 30 minutes to remove non-specific reactants and adsorbed once with appropriate cells, was tested by the indirect immunofluorescent techniques and controls already described (Haire and Hadden, 1970) Tables I and II . In the multiple sclerosis group four patients had measles IgM and two had mumps IgM in their sera; in the group of nervous diseases one patient with post-encephalitic Parkinsonism had measles IgM in his serum, whereas herpes simplex IgM was present in all groups, including the "normal" controls ( Table I ). The patients with multiple sclerosis who had measles and mumps IgM all belonged to category 1. Eight of the same group who had herpes simplex IgM belonged to category 1, two to category 4, and one to category 3. The titres of virus-specific IgG and IgM in second specimens of two sera-one specific for measles and one for mumps -and the values for total IgM are given in Table II , which shows that virus-specific IgM was still present two and a half and three years later. Titres of the virus IgM in other multiple sclerosis sera ranged from 1 in 5 to 1 in 20.
There was no cross-reactive staining between measles and mumps IgM, and the IgM staining factor was removed from the two sera of Table II by absorption with homologous virus but not with heterologous virus. The serum containing measles IgM had a slightly raised total IgM; the serum containing mumps IgM had not.
The results of fluorescent staining of cells are shown in Table III . Bright staining of cell membrane, of cytoplasm or nuclei, or mixtures of these effects, were secn in both virusinfected and uninfected human HEp2 and mouse L cells. Staining of cells was commonest in multiple sclerosis sera, less common in other nervous diseases, and was found only once in the group of "normal" control sera (Table III) . With 379 two exceptions the anticellular antibody was all IgM and 22 of the 27 sera from the multiple sclerosis group belonged to category 1; the remaining five were in the three other categories.
Two sera from category 1 in the multiple sclerosis group, obtained two and a half years after the first specimen, gave the same anticellular staining as before. Anticellular staining was found in six patients who had other nervous diseases. Two of them had motor neurone disease.
Discussion
The principal features of the fluorescence results are the presence of measles IgM and mumps IgM in a small number of sera from multiple sclerosis patients, but not in sera from healthy individuals; the finding of anticellular IgM in a larger number of patient's sera; and the association of both these antibodies with active disease.
It is difficult to draw conclusions from a small number of observations but we believe that the findings are analogous to the association between intracerebral measles antigen and circulating measles IgM which has been reported in three patients who had subacute sclerosing panencephalitis . The persistence of measles IgM for two and a half years and mumps IgM for three years in multiple sclerosis strengthens the comparison, and the even distribution among normal and pathological sera of IgM specific for herpes simplex virus, a recognized latent virus of man, supports the idea.
We do not think that a general hyperactivity of the immune response, which is another possible explanation of our findings, accounts for our detecting only mumps IgM or only measles IgM in a serum. One would expect IgM specific for several viruses to be raised to detectable levels in the same serum. More observations should clarify this point. Though one of our two multiple sclerosis sera tested had a raised total IgM it is worth noting that the incidence of sera showing increased amounts of total IgM has been reported as only 7.8 % of 64 patients (Kolar et al., 1970) .
The association of multiple sclerosis with measles and mumps suggests that one of several different viruses may be involved in the aetiology of the disease, which may account for the varied clinical picture. There is epidemiological evidence that multiple sclerosis may be acquired in childhood and, after a prolonged latency, become clinically manifest (Millar, 1971) . Measles and mumps have been mentioned in this context (Kurtzke, 1968) .
Only six multiple sclerosis patients had virus-specific IgM. This may indicate that our fluorescent antibody tests are not sensitive enough or that IgM specific for other viruses is present in some sera. The virus-specific IgM response could also be poor. Indeed, measles IgM titres in the multiple sclerosis group were much lower than those in subacute sclerosing panencephalitis . It may be relevant that Svehag and Mandel (1964) showed experimentally that very much less antigen is required to induce an IgM response than is required for an IgG response and that the intensity of the response is related to the weight of antigen present.
The anticellular antibody in multiple sclerosis and other nervous diseases was, with two exceptions, all IgM. Most multiple sclerosis patients having anticellular IgM were in the category of active disease. This may be related to a report that anti-brain IgM is present during the active stage of the disease (J. . The variety of forms of anticellular staining and the fact that these were not confined to the sera of multiple sclerosis patients indicate that this immune response is not unique to multiple sclerosis. Those Invcstigations.-Chest x-ray films slhowed progressive patchy consolidation of both mid-zones. Haemoglobin was 10.7 g/100 ml but fell terminally to 7.7 g/100 ml. The platelet count ranged from 64,000 to 40,000/mm:'. The initial total white cell count was 5,300/ mm 3, with 3,000 lymphocytes/mm3, but fell to 1,900/mm', with
